Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 May;82(5):534-7.
doi: 10.1136/bjo.82.5.534.

Impaired motion sensitivity as a predictor of subsequent field loss in glaucoma suspects: the Roscommon Glaucoma Study

Affiliations

Impaired motion sensitivity as a predictor of subsequent field loss in glaucoma suspects: the Roscommon Glaucoma Study

J Wu et al. Br J Ophthalmol. 1998 May.

Abstract

Aim: To determine if impaired motion sensitivity is a significant predictor of subsequent field loss in glaucoma suspects.

Method: A population based prospective study; a 5 year follow up of all glaucoma suspects who had been identified from a population based random sample survey in the west of Ireland. 78 glaucoma suspects whose visual field function was annually measured by Henson CFS 2000 and for whom data on family history of glaucoma, ocular status, and motion impairment had been recorded. Visual field loss was defined as Henson visual field survival score of 94 or less.

Results: 18 people developed visual field loss in at least one eye. Motion impairment at baseline was associated with a 2-18 times greater risk of development of the visual field loss (p < 0.001). This association was independent of sex, family history of glaucoma, intraocular pressure, and C/D ratio at baseline. The Cox's proportional hazards regression analysis confirmed the above results after adjustment for age and the C/D ratio.

Conclusion: Motion impairment is an independent predictor of visual field loss in glaucoma suspects, although it is not clear how long motion impairment precedes visual field loss.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1981 Sep 4;213(4512):1139-42 - PubMed
    1. Arch Ophthalmol. 1980 Dec;98(12):2163-71 - PubMed
    1. Invest Ophthalmol Vis Sci. 1987 Jun;28(6):913-20 - PubMed
    1. J Neurosci. 1987 Nov;7(11):3416-68 - PubMed
    1. Graefes Arch Clin Exp Ophthalmol. 1988;226(6):531-8 - PubMed

Publication types